Product Images Victoza

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 22 images provide visual information about the product associated with Victoza NDC 50090-4503 by A-s Medication Solutions, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Figure 1: Structural Formula of liraglutide - 49f302f5 f315 48b8 83a4 6ca56f01fded 01

Figure 2 Mean Insulin Secretion Rate (ISR) versus Glucose Concentration - 49f302f5 f315 48b8 83a4 6ca56f01fded 02

This is a graph showing the plasma glucose (measured in mg/dL) levels for two groups: one receiving a drug called Victoza and the other group receiving a placebo. The values on the x-axis range from 80 to 220, while the units on the y-axis are not specified. The text "15K {pmol/kg/min)" may be unrelated to this graph.*

Figure 4 Mean HbA1c for patients who completed the 26-week trial and for the Last Observation Carried Forward (LOCF, intent-to-treat) data at Week 26 - 49f302f5 f315 48b8 83a4 6ca56f01fded 04

Victoza Pen and Needle - image 01

This text appears to be a diagram or instruction manual for using a Victoza Pen, with illustrations of the rubber cartridge tip, stopper, dose display, needle, and needle protective covering. It also includes a phone number and website for help with using the pen.*

Fig. A - Pull off pen cap - image 02

Fig. B - Remove protective tab. - image 03

Fig. C and D - - image 04

Fig. E - image 05

Fig. F - image 06

Fig. G - image 07

Fig. H - Pull off pen cap. - image 08

Fig. I - image 09

Fig. J-K - image 10

Fig. L - image 11

Fig. M - image 12

Fig. N - image 13

Fig. O - image 14

Fig. P - image 15

Fig. Q - image 16

Figure 5 - image 20

The text describes a graph or table showing the results of a medical study comparing the drug Victoza to a placebo. The study tracked patients over time, with the x-axis showing months from randomization and the y-axis showing the number of patients at risk. The FAS (full analysis set) is mentioned. The graph or table shows that Victoza had a beneficial effect compared to the placebo, with a HR (hazard ratio) of 0.87 and a confidence interval of 95%.*

Figure 3 - image 21

This appears to be a graph comparing the effectiveness of two diabetes medications, Glimepiride and Victoza, at different doses over time. The graph shows the change in glucose levels over the course of several weeks, with Victoza 1.8mg dosage being the most effective in lowering glucose levels compared to Glimepiride. There are also some statistical values provided in the text.*

Label Image - lbl500904503

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.